semaglutide maker Ozempic Novo Nordisk wants the FDA to crack down on knockoff weight loss drugs nbc semaglutide In a new

Glucagon-like peptide-1 (GLP-1) receptor agonists represent a class of medications that mimic the action of naturally occurring GLP-1, an incretin hormone produced in the intestinal L-cells

Graphics by Brian Olson

HbA1c is your 3-month average blood sugar, so a reduction confirms a real metabolic win

When GLP-1 binds to the receptor it stimulates the signaling of cyclic AMP (cAMP) which is responsible for its multiple therapeutic effects

It works by controlling blood sugar and insulin levels, and studies have found it associated with significant weight loss when taken regularly by overweight or obese individuals who attempt an exercise program

Some users find it helpful to track their injection sites with a simple log or body diagram